Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Schumer calls on Leland Dudek, acting commissioner of SSA, to resign

Related Posts

Trump set to meet with world leaders in...

February 24, 2025

House Freedom Caucus bid to censure Democrat over...

November 19, 2025

Future of Trump budget bill uncertain as House...

April 9, 2025

Trump predicts little progress in potential shutdown talks...

August 14, 2025

Top Republican warns families of ‘largest tax hike...

April 16, 2025

10 key takeaways from DOJ’s release of Ghislaine...

August 23, 2025

Trump offers to release his October MRI results,...

December 2, 2025

Why Trump’s push for frigid Greenland is about...

March 30, 2025

Carney says Canada is not for sale, Trump...

May 7, 2025

Newsom taunts Trump with series of comments about...

July 17, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved